Inventor · disambiguated record
Scott Hunter Watterson
Also filed as: WATTERSON SCOTT H · WATTERSON SCOTT HUNTER
40 granted patents·4 pending applications·181 citations·filing 1999–2024
97Inventor score
Files withBRISTOL MYERS SQUIBB CO31INNATE TUMOR IMMUNITY INC7PITTS WILLIAM J2DAS JAGABANDHU1DHAR T G MURALI1
Top patents by PatentIndex Score
44 records- 0194US9688629B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jun 27, 2017·6 cites·21 claims
- 0293US10913738B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Feb 9, 2021·7 cites·14 claims
- 0391US6916809B2Heterocyclic acridone inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 12, 2005·61 cites·9 claims
- 0489US8354398B2Substituted isoxazole compoundsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 15, 2013·13 cites·12 claims
- 0587US11344543B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2018·Granted May 31, 2022·2 cites·25 claims
- 0686US8404672B2Substituted heterocyclic compoundsPITTS WILLIAM J·Filed 2010·Granted Mar 26, 2013·13 cites·12 claims
- 0785US9334290B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 10, 2016·5 cites·20 claims
- 0885US8389509B2Substituted pyrazole compoundsDYCKMAN ALARIC J·Filed 2010·Granted Mar 5, 2013·15 cites·14 claims
- 0984US2023192645A1Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1083US9920031B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 20, 2018·1 cites·14 claims
- 1181US10947263B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 16, 2021·2 cites·21 claims
- 1281US7186727B2Pyridyl-substituted spiro-hydantoin compounds and use thereofBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Mar 6, 2007·5 cites·8 claims
- 1380US9802915B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 31, 2017·1 cites·15 claims
- 1480US7737279B21,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 15, 2010·4 cites·8 claims
- 1580US6919335B2Heterocycles that are inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 19, 2005·16 cites·22 claims
- 1679US6617323B2Amino-substituted compounds useful as inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Sep 9, 2003·8 cites·10 claims
- 1779US2025074909A1Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1876US11623921B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 11, 2023·0 cites·7 claims
- 1973US12171756B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2022·Granted Dec 24, 2024·0 cites·10 claims
- 2073US10604504B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 31, 2020·0 cites·14 claims
- 2172US2020165222A1Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2270US9216972B2Tricyclic heterocyclic compoundsDHAR T G MURALI·Filed 2010·Granted Dec 22, 2015·2 cites·16 claims
- 2370US8822510B2Substituted 3-phenyl-1,2,4-Oxadiazole compoundsDAS JAGABANDHU·Filed 2011·Granted Sep 2, 2014·3 cites·10 claims
- 2470US7008958B22-substituted 5-oxazolyl indole compounds useful as IMPDH inhibitors and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Mar 7, 2006·4 cites·13 claims
- 2569US10329274B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 25, 2019·0 cites·14 claims
- 2669US9714234B2Carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 25, 2017·1 cites·9 claims
- 2768US10676434B2Carbazole derivativesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 9, 2020·0 cites·8 claims
- 2868US10023534B2Carbazole and tetrahydrocarbazole compounds useful as inhibitors of BTKBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 17, 2018·1 cites·13 claims
- 2967US12157733B2Aminotriazolopyridines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Dec 3, 2024·0 cites·6 claims
- 3067US10435415B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 8, 2019·0 cites·11 claims
- 3167US9850258B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Dec 26, 2017·0 cites·3 claims
- 3267US6420403B1Inhibitors of IMPDH enzymeFiled 1999·Granted Jul 16, 2002·11 cites·23 claims
- 3367US2019382416A1Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 3465US10106559B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·0 cites·11 claims
- 3554US12391675B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Aug 19, 2025·0 cites·13 claims
- 3653US10266491B2Carbazole derivativesBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 23, 2019·0 cites·9 claims
- 3752US12492200B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2021·Granted Dec 9, 2025·0 cites·12 claims
- 3851US12187706B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jan 7, 2025·0 cites·18 claims
- 3950US12338228B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Jun 24, 2025·0 cites·12 claims
- 4050US12150937B2NLRP3 modulatorsINNATE TUMOR IMMUNITY INC·Filed 2020·Granted Nov 26, 2024·0 cites·16 claims
- 4149US7312209B2Acridone inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Dec 25, 2007·0 cites·29 claims
- 4244US11618753B2Aminopyrrolotriazines as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 4, 2023·0 cites·9 claims
- 4342US8268855B21,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising samePITTS WILLIAM J·Filed 2010·Granted Sep 18, 2012·0 cites·8 claims
- 4435US10214537B2Bicyclic heteroaryl amine compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 26, 2019·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →